Kidney Research and Clinical Practice

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period: Hyuk Huh, Yong Soo Kim, Wookyung Chung et al.; Kidney Res Clin Pract. 2023;42(2):216-228. Published online January 13, 2023; DOI: https://doi.org/10.23876/j.krcp.22.024
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Using the Mayo Imaging Classification to predict renal outcomes in Korean autosomal dominant polycystic kidney disease patients: Yeonsoon Jung; Kidney Res Clin Pract. 2022;41(4):389-392. Published online July 19, 2022; DOI: https://doi.org/10.23876/j.krcp.22.016
Web of Science 2 Cited By 2; Full text PubReader ePub PDF

The influence of hypophosphatemia on outcomes of low- and high-intensity continuous renal replacement therapy in critically ill patients with acute kidney injury: Soo Young Kim, Ye Na Kim, Ho Sik Shin, Yeonsoon Jung, Hark Rim; Kidney Res Clin Pract. 2017;36(3):240-249. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.240
Web of Science 9 Cited By 9; Full text PubReader PDF

14,551	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,504	C4d Puzzle in ABO-incompatible kidney transplantation
7,900	How should we treat acute kidney injury caused by renal congestion?
34,798	Uremic pruritus: pathophysiology, clinical presentation, and treatments
12,623	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Search